Archives for October 31, 2018

BBK takes aim at patient, doctor relationships with additions to Clinical Notifier

BBK is looking to bring balance to the doctor, patient relationship by improving lines of communication and the productivity of office visits with its online resource, Clinical Notifier.

Universal flu vaccine candidate demonstrates preclinical success

InvVax’s universal flu vaccine candidate has demonstrated preclinical success as the company prepares for a Phase I clinical trial, supported by a Series A fundraising round.

Sponsors should consider the potential advantages, challenges of master protocols: CRO

Sponsors are encouraged to use a master protocol approach to accelerate clinical development programs, though experts say the advantages and challenges should be carefully weighed.

Sponsors ‘still have further to go’ as 50% of trials go unreported: Report

Clinical trial transparency efforts are falling short, with half of trials left unreported, according to a recent UK parliamentary committee report, which calls on the government to take action.

Halozyme licenses drug-delivery technology to Roche for $25m upfront

Halozyme will provide its drug-delivery technology, Enhanze, to Roche to be used in the development of an undisclosed clinical stage target.

UPDATE FROM SCIEGEN

ScieGen recall: US FDA finds NDEA impurity in first non-valsartan drug

ScieGen Pharmaceuticals has recalled certain batches of hypertension drug irbesartan, after a probable carcinogen was detected in supplier Aurobindo’s API.

Takeda proposes sale of IBD pipeline to close Shire deal

Takeda is in talks to sell Shire’s experimental inflammatory bowel disease pipeline in an effort to meet European regulators approval for the acquisition.